Propanc Biopharma (PPCB) Stock Chart & Stock Price History $3.67 -2.18 (-37.26%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Propanc Biopharma Stock Price Performance The Propanc Biopharma (PPCB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 611,566.67%, with a year-to-date return of 1,834,900.00%. In the past month, the stock has decreased 18.44%, reflecting recent market activity. As of the latest close, Propanc Biopharma traded at $5.85 with a market cap of $111 thousand and volume of 67.93 million shares. Five years ago, the stock traded at a split-adjusted price of $1.70, representing a 115.88% increase over that period. At the time, it had a market cap of $170 thousand and a volume of 24,401 shares. Receive PPCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-64.71%1 Month Performance-18.44%3 Month Performance+25.47%Year-To-Date Performance+1,834,900.00%1 Year Performance+611,566.67%5 Year Performance+115.88% PPCB Stock Chart for Tuesday, August, 19, 2025 PPCB Chart by TradingView Propanc Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$5.85$3.67-37.26%$4.98$3.512.34 million shs$113,000.0008/18/2025$2.87$5.85+103.83%$9.36$5.5767.93 million shs$111,000.0008/15/2025$10.40$2.87-72.40%$4.50$2.82496,043 shs$57,000.0008/14/2025$8.00$10.40+30.00%$10.40$6.002,985 shs$208,000.0008/13/2025$6.21$8.00+28.92%$8.98$4.288,701 shs$152,000.0008/12/2025$9.00$6.21-31.05%$10.72$5.035,106 shs$124,000.0008/11/2025$6.10$9.00+47.54%$9.00$5.011,252 shs$180,000.0008/08/2025$6.10$6.10$6.10$6.1021 shs$122,000.0008/07/2025$6.10$6.10$7.10$6.001,068 shs$116,000.0008/06/2025$9.90$6.10-38.38%$7.10$6.001,068 shs$122,000.00 Get the Latest News and Ratings for PPCB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$9.00$9.90+10.00%$10.50$9.903,143 shs$198,000.0008/04/2025$9.60$9.00-6.25%$9.00$6.00951 shs$171,000.0008/01/2025$9.99$9.60-3.90%$10.81$9.60989 shs$182,000.0007/31/2025$9.49$9.99+5.27%$10.12$7.282,157 shs$200,000.0007/30/2025$7.50$9.49+26.53%$9.49$7.491,661 shs$190,000.0007/29/2025$5.71$7.50+31.39%$7.50$5.803,087 shs$150,000.0007/28/2025$5.92$5.71-3.58%$5.92$4.752,650 shs$114,000.0007/25/2025$4.60$5.92+28.70%$5.92$4.621,506 shs$112,000.0007/24/2025$4.48$4.60+2.68%$4.60$3.945,116 shs$92,000.0007/23/2025$4.48$4.48$4.48$4.484 shs$90,000.0007/22/2025$4.48$4.48$4.48$3.602,003 shs$85,000.0007/21/2025$4.50$4.48-0.44%$4.48$3.602,003 shs$90,000.0007/18/2025$4.99$4.50-9.82%$4.50$4.50187 shs$90,000.00 Related Companies GLG Life Tech Stock Price Chart Nexien Biopharma Stock Price Chart Viracta Therapeutics Stock Price Chart Kaya Stock Price Chart Trevena Stock Price Chart MyMD Pharmaceuticals Stock Price Chart Bon Natural Life Stock Price Chart Capstone Therapeutics Stock Price Chart Vincerx Pharma Stock Price Chart NuCana Stock Price Chart Receive PPCB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PPCB) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Propanc Biopharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Propanc Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access